Via News Contrast:
S&P FAIR VALUE -$0.67 PRE-MARKET.
(AD) Advo issued an earnings and revenue shortfall.
(ARQL) ArQule will receive a milestone payment from Wyeth on a compound used in Alzheimers studies.
(BAX) Baxter gets US FDA approval for Aviva line of IV solutions.
(BAY) Bayer gets FDA orphan drug designation for its Nexanar.
(OTC:BRST) Burst.com filed a patent case against Apple.
(BSX) Boston Scientific $0.46 EPS vs $0.45e.
(CD) Cendant hired CA’s COO to run its ailing travel unit.
(CHB) Champion $0.18 EPS vs $0.16e.
(DGII) DGI Int’l $0.11/R$34.4M vs $0.13/R$35.5M(e).
(DHI) D.R. Horton $1.11 EPS vs $1.12e.
(DJ) Dow Jones $0.14 EPS vs $0.15e.
(DOX) Amdocs pays $275M for Qpass.
(ELS) Equity Lifestyle Properties $0.91 FFO vs $0.92e.
(EMMS) Emmis reported wider losses than expected.
(EXPO) Exponent authorized $35M share buyback plan and announced a 2-1 stock split.
(EZPW) Ezcorp raised guidance.
(FELE) Franklin Electric $0.42 EPS vs $0.34e; unsure if gains in number.
(FCX) Freeport McMoran $1.23 EPS vs $0.88e.
(FITB) Fifth Third Bank $0.65 EPS vs $0.64e.
(IMN) Imation $0.55 EPS vs $0.48e.
(GM:INVX) Innovex $0.04 EPS vs $0.00e.
(JEF) Jefferies $0.82 EPS vs $0.65e.
(JNJ) J&J $0.99 EPS vs $0.98e; earned $1.10 EPS after gain.
(KEY) Keycorp $0.70 EPS vs $0.69e.
(LSE) Capital Lease Funding filed to sell 5M shares.
(MAN) Manpower $0.38 EPS vs $0.38e; guidance looks a tad above estimates.
(MAT) Mattell $0.08 EPS & R$793.3M vs $0.00/$800M(e).
(MEL) Mellon Bank $0.49 EPS vs $0.49e.
(MER) Merrill Lynch $0.44 EPS vs $0.35e.
(MLNM) Millennium Pharma starts Phase III trial for Velcade with J&J.
(MOSS) Mossimo gets a higher bid at $8.00 from Cherokee (CHKE), compared to the $6 cash and $2.50 stock bid from ICON.
(MSFT) Microsoft gets $1.2B software deal from Lenovo.
(MYL) Mylan Labs gets tentative approval for Finasteride.
(NCC) National City $0.74 EPS vs $0.72e.
(NTRS) Northern Trust $0.74 EPS vs $0.68e.
(PHG) Philips Electronics earned 160M Euros vs 222M Euros estimates, unclear if charges are in the number.
(PPDI) Pharm Product Dvplmt. reports Q1 EPS of $0.35 vs $0.34e.
(QBAK) Qualstar lowered guidance.
(REG) Regency Realty guided its Q1 FFO higher.
(RLI) RLI $0.97 EPS vs $0.87e.
(RML) Russell agrees to be acquired by Berkshire Hathaway for $18.00 per share.
(RSAS) RSA Security $0.14/R$87.5M vs $0.13/$85.5M(e); guides slightly higher.
(SHRP) Sharper Image $0.42 EPS vs $0.42e; delays its annual report.
(SNDA) Shanda Interactive signed a technology pact with Hewlett Packard in China.
(SRDX) SurModics licensed its advanced Hydrophilic Technology to Devax.
(STT) State Street $0.87 EPS vs $0.77e; not sure if gains in number.
(SVU) SuperValu $0.55 EPS vs $0.56e.
(SYMC) Symantec disclosed a $1B tax bill demand from the IRS.
(TZOO) Travelzoo $0.24/R$16.9M vs $0.14/$14.7M(e); stock up over 20%.
(UAG) United Auto $0.56 EPS vs $0.56e.
(UIS) Unisys -$0.08/R$1.39B vs -$0.05/$1.39B(e).
(UNH) United Health $0.68 EPS vs $0.65e; sees 2006 EPS $2.88-2.92 vs $2.90e.
(WBS) Webster Financial $0.82 EPS vs $0.81e, but revenues look a tad light.
(WEN) Wendy’s CEO will retire.
(WERN) Werner Enterprise $0.27 EPS vs $0.27e.
(WFC) Wells Fargo $1.19 EPS vs $1.20e.
(WFR) Memc Electronic signs a $1.6B solar wafer supply pact over 8 year with Motech industries.
Cramer’s “Mad Money